We are live on ! Find out more
OSCR icon

Oscar Health

261 hedge funds and large institutions have $2.74B invested in Oscar Health in 2024 Q2 according to their latest regulatory filings, with 75 funds opening new positions, 93 increasing their positions, 63 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 30

130% more call options, than puts

Call options by funds: $90.3M | Put options by funds: $39.2M

48% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 63

19% more funds holding

Funds holding: 220261 (+41)

17% more capital invested

Capital invested by funds: $2.34B → $2.74B (+$404M)

4.94% more ownership

Funds ownership: 80.84%85.79% (+4.9%)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
261
Holders Change
+41
Holders Change %
+18.64%
% of All Funds
3.77%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.12%
New
75
Increased
93
Reduced
63
Closed
30
Calls
$90.3M
Puts
$39.2M
Net Calls
+$51.1M
Net Calls Change
+$26.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$25.6M -$17.5M -953,832 -37%
Prudential Financial
27
Prudential Financial
New Jersey
$24.2M -$6.49M -353,259 -19%
Holocene Advisors
28
Holocene Advisors
New York
$22.8M +$12.9M +700,008 +95%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$22M +$15.8M +860,226 +161%
Northern Trust
30
Northern Trust
Illinois
$21.9M -$557K -30,323 -2%
JP Morgan Chase
31
JP Morgan Chase
New York
$21.7M -$9M -489,498 -26%
Charles Schwab
32
Charles Schwab
California
$21M +$2.5M +136,056 +11%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$20.8M -$3.68M -200,100 -13%
AAP
34
Ardsley Advisory Partners
Connecticut
$20.6M -$1.87M -101,900 -7%
RSCM
35
Rock Springs Capital Management
Maryland
$19.8M -$15.8M -858,500 -41%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$19.6M +$22.7M +1,236,584 New
TI
37
Trexquant Investment
Connecticut
$19.2M +$12.6M +686,448 +130%
Citadel Advisors
38
Citadel Advisors
Florida
$18.8M +$8.14M +442,909 +59%
DCM
39
Driehaus Capital Management
Illinois
$18.7M +$6.57M +357,603 +43%
AA
40
Ancient Art
Texas
$17M -$16.8M -914,417 -46%
Goldman Sachs
41
Goldman Sachs
New York
$16.8M +$1.62M +88,031 +9%
8KM
42
8 Knots Management
Texas
$16.5M
Man Group
43
Man Group
United Kingdom
$14.8M +$17.2M +937,407 New
Point72 Asset Management
44
Point72 Asset Management
Connecticut
$14.7M +$17.1M +930,238 New
Invesco
45
Invesco
Georgia
$13.9M +$12.4M +677,165 +333%
PHS
46
PFM Health Sciences
California
$13.6M
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$13.3M +$3.67M +199,934 +31%
Baillie Gifford & Co
48
Baillie Gifford & Co
United Kingdom
$13M
CPC
49
Cookson Peirce & Co
Pennsylvania
$11.6M +$13.5M +735,808 New
PWAM
50
Park West Asset Management
California
$10.7M -$1.19M -65,000 -9%

OSCR Hedge Fund Activity: Q2 2024 in Review

261 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q2 2024, worth a combined $2.74B — up 17% from $2.34B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new OSCR positions and 30 closed out — a net gain of 45 holders — while 93 added to existing stakes and 63 trimmed.

The largest buyer was Vanguard Group, adding an estimated $51.5M. The largest seller was Deerfield Management, cutting an estimated $44.4M.

  • 261 institutional investors held Oscar Health (OSCR) as of Q2 2024, up from 220 in Q1 2024.
  • Funds reported $2.74B of Oscar Health stock for Q2 2024, up 17% quarter-over-quarter.
  • 75 funds opened new Oscar Health positions in Q2 2024 and 30 closed out, a net change of +45 holders.
  • The largest Oscar Health buyer in Q2 2024 was Vanguard Group, an estimated $51.5M added.
  • The largest Oscar Health seller in Q2 2024 was Deerfield Management, an estimated $44.4M sold.

Based on aggregated 13F filings for Q2 2024.